Marketing Excellence Manager DACH
Ipsen Global
Marketing Excellence Manager DACH
Ipsen Global
Global biopharma focused on specialty care
Title:
Marketing Excellence Manager DACH (f/m/d)Company:
Ipsen Pharma GmbHAbout Ipsen:
Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation.
Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company’s success. Join us on our journey towards sustainable growth, creating real impact on patients and society!
For more information, visit us at https://www.ipsen.com/ and follow our latest news on LinkedIn and Instagram.
Job Description:
To support our Strategic Business Excellence (SBE)-unit in Munich, we are looking for a
Marketing Excellence Manager DACH (f/m/d)
The role turns market, customer and business data into actionable insights that support strategic and commercial decisions across DACH, for both promoted and launch assets. It leads market research and competitive intelligence while developing dashboards and reporting tools that provide a clear, consistent view of brand and market performance.
Your responsibilities
Generate market research and competitive insights
Deliver forecasts and in-market analytics
Support brand planning and launch readiness
What you'll bring
Our offer
Global biopharma focused on specialty care
Ipsen is a global biopharmaceutical company that concentrates on specialty care, developing and marketing medicines for oncology, neuroscience, and rare diseases. Its products work by treating specific high-need conditions, ranging from historical diarrhea treatment Smecta to modern targeted therapies in cancer and neurological disorders. The company differentiates itself through a focused portfolio in niche therapeutic areas, growth via strategic acquisitions, and a long-standing family heritage that shaped its international expansion and IPO-driven capital for expansion. Its goal is to address unmet medical needs worldwide by providing effective therapies for patients with serious or rare conditions.
Explore more opportunities at Ipsen Global